51706-55-9 Usage
Description
4-Hydroxyphentermine is a chemical compound that is structurally similar to phentermine, a medication used for weight loss. It is an active metabolite of phentermine, meaning it is a product of the body's metabolism of the drug. 4-Hydroxyphentermine has been found to possess similar effects to phentermine in terms of appetite suppression and weight loss, making it a potentially useful compound for the treatment of obesity.
Used in Pharmaceutical Industry:
4-Hydroxyphentermine is used as an appetite suppressant for promoting weight loss. Its similarity to phentermine and its role as an active metabolite contribute to its potential effectiveness in managing obesity. However, due to potential side effects and risks, especially for individuals with certain medical conditions or those taking other medications, it is crucial for individuals considering the use of this compound to consult with a healthcare professional before doing so.
Check Digit Verification of cas no
The CAS Registry Mumber 51706-55-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,7,0 and 6 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 51706-55:
(7*5)+(6*1)+(5*7)+(4*0)+(3*6)+(2*5)+(1*5)=109
109 % 10 = 9
So 51706-55-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO/c1-10(2,11)7-8-3-5-9(12)6-4-8/h3-6,12H,7,11H2,1-2H3
51706-55-9Relevant articles and documents
Potent benzimidazolone based human β3-adrenergic receptor agonists
Finley, Don R.,Bell, Michael G.,Borel, Anthony G.,Bloomquist, William E.,Cohen, Marlene L.,Heiman, Mark. L.,Kriauciunas, Aidas,Matthews, Donald P.,Miles, Tania,Neel, David A.,Rito, Christopher J.,Sall, Daniel J.,Shuker, Anthony J.,Stephens, Thomas W.,Tinsley, Frank C.,Winter, Mark A.,Jesudason, Cynthia D.
, p. 5691 - 5694 (2007/10/03)
The synthesis and biological evaluation of a series of benzimidazolone β3 adrenergic receptor agonists are described. A trend toward the reduction of rat atrial tachycardia upon increasing steric bulk at the 3-position of the benzimidazolone mo
4-(2-Amino-2-methylpropyl)phenols by fluoride ion catalysed reaction of 4-hydroxybenzyl alcohols with 2-nitropropane
Renger
, p. 193 - 201 (2007/10/02)
-